Meniere,s disease. Meniere,s disease
Conditions
Interventions
Intervention 1: intervention group 1- gentamicin with dose 27.6 mg once via intra tympanic injection. Intervention 2: intervention group 2- methyl perednosolone with dose 62.5 mg weekly intra tympani
Treatment - Drugs
intervention group 1- gentamicin with dose 27.6 mg once via intra tympanic injection
intervention group 2- methyl perednosolone with dose 62.5 mg weekly intra tympanic injection in three times
Sponsors
Deputy for research of Avaz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with unilateral meniere's disease; Exclusion criteria: patients with bilateral meniere's disease; patients whose involved ear is the only hearing ear; not suffering from central nervous system disease; dissatisfaction
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vertigo. Timepoint: before treatment and 3 months later. Method of measurement: Questennaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Tinnitus. Timepoint: before treatment and 3 month later. Method of measurement: Questennaire.;Hearing loss. Timepoint: before treatment and 3 month later. Method of measurement: audiometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArmin Arad
Ahvaz University of Medical Sciences
Outcome results
None listed